Kristen Ambrose, CAO of Vertex Pharmaceuticals VRTX, has filed 0 purchases and 15 sales on the open market. Over the past 12 months that comes to a net sale of $2M. The latest trade was on 02/26.

KA

KA

Kristen Ambrose

SVP & Chief Accounting Officer

Company

Vertex Pharmaceuticals VRTX

First filing

23/02/03

Trades

38 trades

Buys / sales

0 / 15

12-month net buying

−$2M

Last trade

02/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/26	03/02	357 sh	$483.36	$172,559.52	−5.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/25	02/26	223 sh	$486.35	$108,456.05	−3.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/17–02/18	02/19	2,195 sh2 trades	$484.87avg.	$1,064,297.06	−22.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/11	02/12	1,376 sh	$460.43	$633,551.68	−12.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/25	25/02/26	884 sh	$480.95	$425,159.8	−8.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/18	25/02/19	671 sh	$455.06	$305,345.26	−5.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/11	25/02/12	1,376 sh	$459.83	$632,726.08	−12.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/04/02	24/04/03	240 sh	$419.00	$100,560	−3.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/26	24/02/27	883 sh	$425.70	$375,893.1	−10.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/12	24/02/13	1,374 sh	$420.24	$577,409.76	−12.4%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/05/30	23/06/01	289 sh	$329.82	$95,317.98	−4.1%
Vertex PharmaceuticalsVRTX	Open-market sale	23/02/27	23/02/28	1,207 sh3 trades	$287.55avg.	$347,072.4	−14.2%